Psoriasis may have some common symptoms, but not all skin looks the same.

Patients with psoriasis and eczema now have a new option for reducing inflammation at Columbus Dermatology Clinic. Do you ...

Adults with psoriasis who received text messages with guidance on diet, exercise and other lifestyle strategies engaged in ...

A cohort analysis finds that risankizumab shows the lowest risk for serious infections compared to other systemic therapies ...

In this video from the American Academy of Dermatology Annual Meeting, Eingun James Song, MD, FAAD, discusses differences in ...

When you have psoriasis, your immune system overreacts and causes inflammation. It can cause plaques -- red, thick, itchy, inflamed patches of skin -- along with silver-colored scales, cracked skin, ...

A real-world study found tildrakizumab improved skin clearance, symptoms, and quality of life in adults with plaque psoriasis ...

Mounting evidence of improved outcomes as add-on to psoriasis drugs in patients with obesi ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients randomized ...

Among patients with psoriasis affecting special anatomical sites, IL-17 inhibitors are associated with significant improvements in PASI 75 and 90.

While AD, acne, and HS were more common among Black children, they were less likely than other racial groups to receive dermatology care across all studied conditions in a multicenter US study.